Two Strategies Lead to Similar Survival in RCC MedPage Today Another presentation at GuCS showed that patients who underwent cytoreductive nephrectomy prior to targeted therapy had an OS more than double that of patients who did not have surgery. However, the magnitude of the survival benefit hinged on patient ... |
